We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Rapid Breath Sensor Detects SARS-CoV-2 from Exhaled Air

By LabMedica International staff writers
Posted on 18 Aug 2026

Nasal swabs and polymerase chain reaction (PCR) testing have been central to identifying SARS-CoV-2, but they can be uncomfortable, slow, and logistically complex when samples require transport. More...

Point-of-care alternatives that provide immediate results without sample handling could streamline infection control, particularly when patients are most contagious. Noninvasive breath-based testing could further reduce barriers to frequent screening.

Engineers at Northeastern University have developed a handheld gas-sensing device that captures viral particles in a person’s breath and produces near-instant readouts, similar to a Breathalyzer. The platform uses a molecularly imprinted polymer (MIP), a synthetic material molded around a target molecule to form microscopic cavities that selectively capture specific viral particles, including the SARS-CoV-2 spike protein. The sensor combines a silicon base with a graphene layer; when viral particles bind to the MIP cavities, the device’s electrical resistance changes, generating a detectable signal.

The team refined the technology through multiple generations to improve sensitivity and selectivity, enabling the sensor to recognize its target biomarker while largely ignoring other volatile organic compounds in exhaled breath. The device performs best early in infection, when individuals are actively shedding virus, with performance declining as contagiousness decreases. The SARS-CoV-2 application has received a U.S. Patent and Trademark Office patent and has demonstrated high sensitivity and accuracy, although the researchers note that further testing is needed before the technology can be used for clinical diagnosis.

Because the MIP layer can be re-engineered to fit different targets, the same sensing strategy is being adapted for additional analytes. The group mentions ongoing work on sensors for disease-associated particles such as glucose for diabetes and certain RNA molecules relevant to cancer detection, as well as for substances including fentanyl. Larger-scale testing is cited as a next step before any move toward commercialization.

“It's even faster than a swab test and much more user-friendly,” said Nian Sun, distinguished professor of electrical and computer engineering at Northeastern University.

“The beauty of our sensor is that we can readily change our sensors for newly appearing or newly emerging pathogens,” added Sun.

Related Links
Northeastern University 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Automated Urinalysis Solution
UN-9000
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Skin samples from people with a suspected genetic myopathy were examined for confirmation of disease. Brown spots show abnormal protein buildup inside the nuclei of cells (purple), typical of a type of myopathy called oculopharyngodistal myopathy. (Image Credit: Garvan Institute)

Long-Read Sequencing Test Identifies Genetic Causes in Inherited Muscle Disease

Inherited muscle diseases are highly heterogeneous and often progressive, leaving many patients without a molecular diagnosis despite extensive testing. Conventional assays typically target individual... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.